self-assembling peptide p11-4
Peptideexperimental
Clinical trial activity
5 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Jan 10, 2019 (NCT03927794)
Timeline
2020s
- Jan 1, 2022
Earliest Phase 3 Sponsor(trial)
Indications
Studied for
Mechanism of action
- HydroxyapatiteSupplementation
Hydroxyapatite supplementation
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07146464 | N/A | Mar 27, 2024 | Ain Shams University |
| NCT05584878 | N/A | Jan 1, 2023 | Alexandria University |
| NCT05206539 | Phase 3 | Sep 30, 2022 | Plovdiv Medical University |
| NCT05064137 | N/A | Dec 31, 2021 | Cairo University |
| NCT03927794 | N/A | Jan 10, 2019 | Ain Shams University |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Ain Shams University | Academic/Hospital | 2 | 2 | 1 | 2019 |
| Alexandria University | Academic/Hospital | 1 | 1 | 1 | 2023 |
| Cairo University | Academic/Hospital | 1 | 1 | 1 | 2021 |
| Plovdiv Medical University | Academic/Hospital | 1 | 1 | 1 | 2022 |
4 organizations
Page 1 / 1